Stocks
Iovance Biotherapeutics (IOVA) R&D US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 259.0 | 294.8 | 344.1 | 282.3 | 300.3 | 285.9 | |||
| Changes by years, y/y, % | +28% | +14% | +17% | -18% | +6% | +8.3% | |||
Iovance Biotherapeutics. R&D, bln rub
Iovance Biotherapeutics. R&D, changes, %
Iovance Biotherapeutics. R&D, sum by quarters, bln rub
Iovance Biotherapeutics (IOVA) R&D US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| R&D, bln rub | 76.9 | 79.4 | 75.2 | 68.9 | 62.5 | 285.9 | ||
| Changes by years, y/y, % | -4% | +28% | +10% | -5% | -19% | |||
| Changes by quarters, q/q, % | +6% | +3% | -5% | -8% | -9% | |||
